These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 15929038

  • 1. Molecular pathology and clinical characteristics of oligodendroglial neoplasms.
    Walker C, du Plessis DG, Joyce KA, Fildes D, Gee A, Haylock B, Husband D, Smith T, Broome J, Warnke PC.
    Ann Neurol; 2005 Jun; 57(6):855-65. PubMed ID: 15929038
    [Abstract] [Full Text] [Related]

  • 2. Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.
    Walker C, Haylock B, Husband D, Joyce KA, Fildes D, Jenkinson MD, Smith T, Broome J, du Plessis DG, Warnke PC.
    Neurology; 2006 Jun 13; 66(11):1661-7. PubMed ID: 16769937
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.
    Walker C, Haylock B, Husband D, Joyce KA, Fildes D, Jenkinson MD, Smith T, Broome J, Kopitzki K, du Plessis DG, Prosser J, Vinjamuri S, Warnke PC.
    Br J Cancer; 2006 Nov 20; 95(10):1424-31. PubMed ID: 17031404
    [Abstract] [Full Text] [Related]

  • 8. Phenotype versus genotype in gliomas displaying inter- or intratumoral histological heterogeneity.
    Walker C, du Plessis DG, Joyce KA, Machell Y, Thomson-Hehir J, Al Haddad SA, Broome JC, Warnke PC.
    Clin Cancer Res; 2003 Oct 15; 9(13):4841-51. PubMed ID: 14581356
    [Abstract] [Full Text] [Related]

  • 9. MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes.
    Jenkinson MD, Smith TS, Joyce K, Fildes D, du Plessis DG, Warnke PC, Walker C.
    Neurology; 2005 Jun 28; 64(12):2085-9. PubMed ID: 15985578
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Can morphology predict 1p/19q loss in oligodendroglial tumours?
    Scheie D, Cvancarova M, Mørk S, Skullerud K, Andresen PA, Benestad I, Helseth E, Meling T, Beiske K.
    Histopathology; 2008 Nov 28; 53(5):578-87. PubMed ID: 18983467
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis.
    Barbashina V, Salazar P, Ladanyi M, Rosenblum MK, Edgar MA.
    Am J Surg Pathol; 2007 Aug 28; 31(8):1196-202. PubMed ID: 17667543
    [Abstract] [Full Text] [Related]

  • 18. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
    Weller M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A, German Glioma Network.
    Clin Cancer Res; 2007 Dec 01; 13(23):6933-7. PubMed ID: 18056167
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.